Germany
Japan
United Kingdom
China
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
Download
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR094F2
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Mouse anti-PROM1 (CD133) monoclonal antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ACTB |
TA349205 is a possible alternative to TA349208.
USD 524.00
In Stock
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-BDNF antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IgG fraction antibody was prepared from rabbit antiserum after repeated immunizations with recombinant truncated human BDNF protein produced in E.coli. |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Rabbit Polyclonal Antibody against PROX1 (Center)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PROX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 185-214 amino acids from the Central region of human PROX1. |
Goat Polyclonal Anti-VEGFR2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli. |
Goat Polyclonal Antibody against DKK1
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CDHHQASNSSRLHT, from the C Terminus of the protein sequence according to NP_036374. |
Anti-GAPDH mouse mAb (Loading control)
| Applications | WB |
| Reactivities | Human, Monkey, Mouse, Rat, Dog |
| Conjugation | Unconjugated |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Rabbit polyclonal Neuro D (Ser274) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neuro D around the phosphorylation site of serine 274 (P-L-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit Polyclonal CD44 (Ser706) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD44 around the phosphorylation site of Serine 706 |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified Recombinant peptide derived from within residues 601 to 701 of human CDH1 produced in E. coli. |
Rabbit Polyclonal Antibody against SOX2 - Embryonic Stem Cell Marker
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Sheep |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to the N-terminal region of human SOX2 protein (within residues 1-100). [Swiss-Prot# P48431] |
Active filters
Category
- Antibodies
Reactivities
- Human
Applications
- WB
Conjugates
- Unconjugated
Families
- ES Cell Differentiation/IPS
Availabilities
- In Stock
Filter by
Target Symbol
- CD4 (77)
- JUN (73)
- GLI1 (60)
- EGFR (54)
- PECAM1 (51)
- EPCAM (50)
- CTNNB1 (49)
- VIM (49)
- ABCB1 (48)
- AKT1 (32)
- PTPRC (32)
- PROCR (31)
- CD44 (30)
- NCAM1 (30)
- MKI67 (28)
- TNFRSF8 (28)
- NKX2-1 (27)
- BCL2 (25)
- KIT (25)
- L1CAM (25)
- PIK3CG (25)
- GFAP (24)
- STAT5A (23)
- CSF3 (22)
- FGF21 (22)
- GATA3 (22)
- BSG (21)
- FCGR2A (21)
- ICAM3 (21)
- KRT7 (21)
- PDGFRA (21)
- TNNI3 (21)
- PDGFRB (20)
- CDH1 (18)
- CSF2 (18)
- CDH2 (17)
- SMAD1 (17)
- PDX1 (16)
- CD34 (15)
- MCAM (15)
- NEUROG1 (15)
- VCAM1 (15)
- CASP3 (14)
- GAPDH (14)
- LHX1 (14)
- TAL1 (14)
- CDX2 (13)
- ENG (13)
- ENPEP (13)
- HES1 (13)
- HNF4A (13)
- SIGLEC7 (13)
- AKT2 (12)
- BCL2L1 (12)
- KDR (12)
- SERPINA1 (12)
- SPN (12)
- CD14 (11)
- DVL2 (11)
- MAPK8 (11)
- MAPK9 (11)
- PTCH1 (11)
- SRC (11)
- CDCP1 (10)
- CPA1 (10)
- ID3 (10)
- PRKCA (10)
- SOX2 (10)
- ANGPT1 (9)
- IGFBP1 (9)
- MAPK3 (9)
- ANPEP (8)
- DLX1 (8)
- GATA4 (8)
- HOXD8 (8)
- IRF6 (8)
- PLAU (8)
- RUNX1 (8)
- SOX9 (8)
- YBX1 (8)
- ZFP42 (8)
- ACTB (7)
- CSF1 (7)
- FN1 (7)
- HGF (7)
- KLF5 (7)
- MPI (7)
- NOTCH1 (7)
- TAZ (7)
- TGFB1 (7)
- ACTN1 (6)
- CD8A (6)
- CST3 (6)
- EVX1 (6)
- FAS (6)
- GNL3 (6)
- ICAM1 (6)
- ID2 (6)
- IGF1 (6)
- ITGB1 (6)
Antibody Hosts
Isotypes
Clonalities
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (657)
- Focal adhesion (434)
- Colorectal cancer (392)
- Cell adhesion molecules (CAMs) (369)
- MAPK signaling pathway (324)
- T cell receptor signaling pathway (300)
- ErbB signaling pathway (284)
- Prostate cancer (265)
- Cytokine-cytokine receptor interaction (260)
- Hematopoietic cell lineage (258)
- Melanoma (235)
- Regulation of actin cytoskeleton (213)
- Endometrial cancer (210)
- Neurotrophin signaling pathway (203)
- Glioma (197)
- Pancreatic cancer (193)
- Leukocyte transendothelial migration (191)
- Wnt signaling pathway (191)
- Toll-like receptor signaling pathway (187)
- GnRH signaling pathway (180)
- Adherens junction (176)
- Epithelial cell signaling in Helicobacter pylori infection (174)
- Jak-STAT signaling pathway (169)
- Renal cell carcinoma (169)
- B cell receptor signaling pathway (156)
- Acute myeloid leukemia (154)
- Endocytosis (150)
- Non-small cell lung cancer (150)
- Basal cell carcinoma (149)
- Fc gamma R-mediated phagocytosis (149)
- Chronic myeloid leukemia (142)
- Gap junction (135)
- Tight junction (132)
- Fc epsilon RI signaling pathway (131)
- Apoptosis (129)
- Small cell lung cancer (128)
- Primary immunodeficiency (115)
- VEGF signaling pathway (114)
- Progesterone-mediated oocyte maturation (111)
- Calcium signaling pathway (110)
- Melanogenesis (108)
- Insulin signaling pathway (106)
- Pathogenic Escherichia coli infection (106)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (99)
- Hedgehog signaling pathway (95)
- Natural killer cell mediated cytotoxicity (95)
- Chemokine signaling pathway (91)
- Antigen processing and presentation (90)
- mTOR signaling pathway (89)
- TGF-beta signaling pathway (87)
- Bladder cancer (86)
- Thyroid cancer (78)
- Type II diabetes mellitus (74)
- Adipocytokine signaling pathway (71)
- Dorso-ventral axis formation (70)
- Maturity onset diabetes of the young (67)
- Hypertrophic cardiomyopathy (HCM) (64)
- Dilated cardiomyopathy (59)
- ECM-receptor interaction (58)
- Amyotrophic lateral sclerosis (ALS) (57)
- ABC transporters (48)
- Prion diseases (47)
- Alzheimer's disease (44)
- Metabolic pathways (43)
- Axon guidance (42)
- Notch signaling pathway (40)
- Phosphatidylinositol signaling system (35)
- Systemic lupus erythematosus (34)
- Viral myocarditis (33)
- NOD-like receptor signaling pathway (31)
- Renin-angiotensin system (26)
- p53 signaling pathway (26)
- Inositol phosphate metabolism (25)
- Long-term depression (25)
- RIG-I-like receptor signaling pathway (22)
- Cardiac muscle contraction (21)
- Complement and coagulation cascades (20)
- Cell cycle (19)
- Long-term potentiation (19)
- Vascular smooth muscle contraction (19)
- Huntington's disease (18)
- Oocyte meiosis (17)
- Vibrio cholerae infection (17)
- Autoimmune thyroid disease (15)
- Glycolysis / Gluconeogenesis (15)
- Allograft rejection (14)
- Parkinson's disease (14)
- Type I diabetes mellitus (14)
- Graft-versus-host disease (12)
- Glutathione metabolism (8)
- Amino sugar and nucleotide sugar metabolism (7)
- Fructose and mannose metabolism (7)
- Nicotinate and nicotinamide metabolism (7)
- Ubiquitin mediated proteolysis (6)
- Lysosome (5)
- Retinol metabolism (4)
- Neuroactive ligand-receptor interaction (3)
- Asthma (2)
- Cysteine and methionine metabolism (2)
- Drug metabolism - cytochrome P450 (2)
- Drug metabolism - other enzymes (2)
- Linoleic acid metabolism (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Phenylalanine (2)
- Phenylalanine metabolism (2)
- Purine metabolism (2)
- Pyrimidine metabolism (2)
- Regulation of autophagy (2)
- Tyrosine metabolism (2)
- Ubiquinone and other terpenoid-quinone biosynthesis (2)
- tyrosine and tryptophan biosynthesis (2)
- Citrate cycle (TCA cycle) (1)
- PPAR signaling pathway (1)
- Pyruvate metabolism (1)